Ethyl 3,4-dihydroxybenzoate
Code | Size | Price |
---|
TAR-T5684-500mg | 500mg | £103.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T5684-1mL | 1 mL * 10 mM (in DMSO) | £107.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Ethyl 3,4-dihydroxybenzoate (EDHB): a prolyl hydroxylase inhibitor attenuates acute hypobaric hypoxia mediated vascular leakage in brain.
CAS:
3943-89-3
Formula:
C9H10O4
Molecular Weight:
182.175
Pathway:
; Metabolism; Immunology/Inflammation; NF-κb; Chromatin/Epigenetic; Autophagy; Apoptosis
Purity:
0.98
SMILES:
CCOC(=O)c1ccc(O)c(O)c1
Target:
Apoptosis; Reactive Oxygen Species; HIF/HIF Prolyl-Hydroxylase; NO Synthase; Autophagy
References
Singh D P , Nimker C , Paliwal P , et al. Ethyl 3,4-dihydroxybenzoate (EDHB): a prolyl hydroxylase inhibitor attenuates acute hypobaric hypoxia mediated vascular leakage in brain[J]. The Journal of Physiological Sciences, 2016, 66(4):315-326.
Nandan D , Clarke E P , Ball E H , et al. Ethyl-3,4-dihydroxybenzoate inhibits myoblast differentiation: Evidence for an essential role of collagen[J]. The Journal of Cell Biology, 1990, 110(5):1673-1679.